These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 27600062)

  • 21. Comparable survival outcome of metastatic colorectal cancer in Indigenous and non-Indigenous patients: Retrospective analysis of the South Australian metastatic colorectal cancer registry.
    Tomita Y; Karapetis CS; Roder D; Beeke C; Hocking C; Roy AC; Townsend AR; Padbury R; Maddern G; Price TJ
    Aust J Rural Health; 2016 Apr; 24(2):85-91. PubMed ID: 26255652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemotherapy for colorectal cancer in the elderly.
    Kim JH
    World J Gastroenterol; 2015 May; 21(17):5158-66. PubMed ID: 25954089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Palliative treatment for elderly patients with colon cancer in ten Italian medical oncology units.
    Pasetto LM; Falci C; Rizzo E; De Salvo GL; Gasparini G; D'Andrea M; Bajetta E; Platania M; Alabiso O; Miraglia S; Oniga F; Biason R; Chetrì MC; Fedele P; Massara G; Romaniello I; Giordano M; Luchena G; Buzzi F; Ricotta R; Siena S; Monfardini S
    Anticancer Res; 2008; 28(3B):1813-20. PubMed ID: 18630465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elderly patients with colorectal cancer: treatment modalities and survival in France. National data from the ThInDiT cohort study.
    Doat S; Thiébaut A; Samson S; Ricordeau P; Guillemot D; Mitry E
    Eur J Cancer; 2014 May; 50(7):1276-83. PubMed ID: 24447833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and toxicity of bevacizumab on combination with chemotherapy in different lines of treatment for metastatic colorectal carcinoma.
    Kiss I; Bortlicek Z; Melichar B; Poprach A; Halamkova J; Vyzula R; Dusek L; Buchler T
    Anticancer Res; 2014 Feb; 34(2):949-54. PubMed ID: 24511038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemotherapy and targeted agents for colorectal cancer in a real-life setting anticipate guidelines: the COLCHIC cohort study.
    Smith D; Terrebonne E; Rouyer M; Blanc JF; Breilh D; Pedeboscq S; Le Monies A; Lecomte C; Lassalle R; Moore N; Fourrier-Réglat A
    Fundam Clin Pharmacol; 2013 Feb; 27(1):113-9. PubMed ID: 21793898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Durable complete responses in metastatic colorectal cancer treated with chemotherapy alone.
    Ferrarotto R; Pathak P; Maru D; Agarwal A; Overman M; Hoff PM; Kopetz S
    Clin Colorectal Cancer; 2011 Sep; 10(3):178-82. PubMed ID: 21855039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment patterns and metastasectomy among mCRC patients receiving chemotherapy and biologics.
    Song X; Zhao Z; Barber B; Gregory C; Wang PF; Long SR
    Curr Med Res Opin; 2011 Jan; 27(1):123-30. PubMed ID: 21128878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival analysis of metastatic colorectal cancer patients who were treated with the five major therapeutic agents over the course of disease.
    Varol U; Cirak Y; Cakar B; Karaca B; Sezgin C; Uslu R; Karabulut B
    J BUON; 2013; 18(3):647-52. PubMed ID: 24065478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of metastatic colorectal cancer.
    Davies JM; Goldberg RM
    Semin Oncol; 2011 Aug; 38(4):552-60. PubMed ID: 21810514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activating KRAS mutations and overexpression of epidermal growth factor receptor as independent predictors in metastatic colorectal cancer patients treated with cetuximab.
    Yen LC; Uen YH; Wu DC; Lu CY; Yu FJ; Wu IC; Lin SR; Wang JY
    Ann Surg; 2010 Feb; 251(2):254-60. PubMed ID: 20010090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical trial enrollment, patient characteristics, and survival differences in prospectively registered metastatic colorectal cancer patients.
    Sorbye H; Pfeiffer P; Cavalli-Björkman N; Qvortrup C; Holsen MH; Wentzel-Larsen T; Glimelius B
    Cancer; 2009 Oct; 115(20):4679-87. PubMed ID: 19562777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiepidermal growth factor receptor monoclonal antibody improves survival outcomes in the treatment of patients with metastatic colorectal cancer.
    Wang L; Chen X; Li W; Sheng Z
    Anticancer Drugs; 2012 Feb; 23(2):155-60. PubMed ID: 21955998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Folfirinox in elderly patients with pancreatic or colorectal cancer-tolerance and efficacy.
    Guion-Dusserre JF; Bertaut A; Ghiringhelli F; Vincent J; Quipourt V; Marilier S; Tharin Z; Bengrine-Lefevre L
    World J Gastroenterol; 2016 Nov; 22(42):9378-9386. PubMed ID: 27895425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemotherapy compliance, tolerance and efficacy in elderly and non-elderly patients with metastatic colorectal cancer: a single institution comparative study.
    Bakogeorgos M; Mountzios G; Kotsantis G; Economopoulou P; Fytrakis N; Kentepozidis N
    J BUON; 2013; 18(3):629-34. PubMed ID: 24065475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What constitutes best supportive care in the treatment of advanced non-small cell lung cancer patients?--Results from the lung cancer economics and outcomes research (LUCEOR) study.
    Lester JF; Agulnik J; Akerborg O; Chouaid C; De Geer A; Finnern HW; Herder GJ; Lungershausen J; Mitchell PL; Vansteenkiste J; Ziske C; Goker E
    Lung Cancer; 2013 Oct; 82(1):128-35. PubMed ID: 23910909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association Between Use of Anticancer Drugs and Cardiovascular Disease-Related Hospitalization in Metastatic Colorectal Cancer: Insights From a Population-Based Study, the Anticancer Vigilance of Cardiac Events Study.
    Dolladille C; Launoy G; Bouvier V; Salem JE; Legallois D; Milliez P; Sassier M; Lobbedez T; Guittet L; Alexandre J
    Am J Epidemiol; 2021 Feb; 190(3):376-385. PubMed ID: 32964219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness analysis of panitumumab plus mFOLFOX6 compared with bevacizumab plus mFOLFOX6 for first-line treatment of patients with wild-type RAS metastatic colorectal cancer.
    Graham CN; Hechmati G; Hjelmgren J; de Liège F; Lanier J; Knox H; Barber B
    Eur J Cancer; 2014 Nov; 50(16):2791-801. PubMed ID: 25219451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
    Song A; Eo W; Lee S
    World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical outcomes associated with bevacizumab-containing treatment of metastatic colorectal cancer: the BRiTE observational cohort study.
    Kozloff M; Yood MU; Berlin J; Flynn PJ; Kabbinavar FF; Purdie DM; Ashby MA; Dong W; Sugrue MM; Grothey A;
    Oncologist; 2009 Sep; 14(9):862-70. PubMed ID: 19726453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.